News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
850,222 Results
Type
Article (86668)
Company Profile (703)
Press Release (762849)
Multimedia
Podcasts (137)
Webinars (17)
Section
Business (232748)
Career Advice (4129)
Deals (39738)
Drug Delivery (129)
Drug Development (91043)
Employer Resources (198)
FDA (18145)
Job Trends (17349)
News (396639)
Policy (39782)
Tag
Academia (3002)
Academic (2)
Accelerated approval (7)
Adcomms (32)
Allergies (99)
Alliances (56913)
ALS (112)
Alzheimer's disease (1531)
Antibody-drug conjugate (ADC) (180)
Approvals (18089)
Artificial intelligence (361)
Autoimmune disease (33)
Automation (18)
Bankruptcy (405)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (123)
Biotechnology (481)
Bladder cancer (92)
Brain cancer (36)
Breast cancer (368)
Cancer (2830)
Cardiovascular disease (227)
Career advice (3536)
Career pathing (34)
CAR-T (196)
Cell therapy (541)
Cervical cancer (22)
Clinical research (73899)
Collaboration (1002)
Company closure (3)
Compensation (623)
Complete response letters (30)
COVID-19 (2892)
CRISPR (59)
C-suite (304)
Cystic fibrosis (114)
Data (2756)
Decentralized trials (2)
Denatured (48)
Depression (63)
Diabetes (322)
Diagnostics (6952)
Digital health (24)
Diversity (9)
Diversity, equity & inclusion (49)
Drug discovery (162)
Drug pricing (145)
Drug shortages (35)
Duchenne muscular dystrophy (116)
Earnings (97400)
Editorial (48)
Employer branding (25)
Employer resources (168)
Events (131070)
Executive appointments (862)
FDA (19702)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (10)
Funding (913)
Gene editing (136)
Generative AI (36)
Gene therapy (406)
GLP-1 (883)
Government (5201)
Grass and pollen (6)
Guidances (179)
Healthcare (20911)
Huntington's disease (29)
IgA nephropathy (38)
Immunology and inflammation (167)
Immuno-oncology (6)
Indications (34)
Infectious disease (3063)
Inflammatory bowel disease (160)
Inflation Reduction Act (12)
Influenza (63)
Intellectual property (112)
Interviews (813)
IPO (17875)
IRA (53)
Job creations (5191)
Job search strategy (2861)
Kidney cancer (15)
Labor market (51)
Layoffs (577)
Leadership (25)
Legal (10125)
Liver cancer (82)
Lung cancer (403)
Lymphoma (188)
Machine learning (9)
Management (65)
Manufacturing (400)
MASH (90)
Medical device (14679)
Medtech (14684)
Mergers & acquisitions (22511)
Metabolic disorders (861)
Multiple sclerosis (99)
NASH (23)
Neurodegenerative disease (130)
Neuropsychiatric disorders (37)
Neuroscience (2218)
NextGen: Class of 2025 (7686)
Non-profit (5087)
Now hiring (44)
Obesity (455)
Opinion (283)
Ovarian cancer (96)
Pain (110)
Pancreatic cancer (106)
Parkinson's disease (182)
Partnered (25)
Patents (283)
Patient recruitment (137)
Peanut (53)
People (65518)
Pharmaceutical (143)
Pharmacy benefit managers (24)
Phase I (22823)
Phase II (32096)
Phase III (24153)
Pipeline (1579)
Policy (204)
Postmarket research (3552)
Preclinical (10294)
Press Release (72)
Prostate cancer (136)
Psychedelics (39)
Radiopharmaceuticals (276)
Rare diseases (481)
Real estate (7397)
Recruiting (75)
Regulatory (26953)
Reports (61)
Research institute (2663)
Resumes & cover letters (649)
Rett syndrome (9)
RNA editing (9)
RSV (52)
Schizophrenia (90)
Series A (156)
Series B (105)
Service/supplier (30)
Sickle cell disease (62)
Special edition (21)
Spinal muscular atrophy (166)
Sponsored (35)
Startups (4297)
State (2)
Stomach cancer (16)
Supply chain (79)
Tariffs (62)
The Weekly (87)
Vaccines (858)
Venture capitalists (49)
Weight loss (312)
Women's health (45)
Worklife (20)
Date
Today (69)
Last 7 days (632)
Last 30 days (3340)
Last 365 days (34849)
2025 (15761)
2024 (38139)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1272)
Alabama (66)
Alaska (7)
Arizona (277)
Arkansas (14)
Asia (50357)
Australia (8854)
California (7324)
Canada (2270)
China (655)
Colorado (311)
Connecticut (327)
Delaware (185)
Europe (115531)
Florida (1074)
Georgia (248)
Hawaii (1)
Idaho (65)
Illinois (703)
India (31)
Indiana (365)
Iowa (16)
Japan (211)
Kansas (115)
Kentucky (30)
Louisiana (17)
Maine (73)
Maryland (1051)
Massachusetts (5599)
Michigan (265)
Minnesota (455)
Mississippi (3)
Missouri (95)
Montana (32)
Nebraska (26)
Nevada (77)
New Hampshire (72)
New Jersey (2034)
New Mexico (31)
New York (2047)
North Carolina (1202)
North Dakota (10)
Northern California (3164)
Ohio (242)
Oklahoma (16)
Oregon (48)
Pennsylvania (1570)
Puerto Rico (17)
Rhode Island (39)
South America (1653)
South Carolina (32)
South Dakota (1)
Southern California (2697)
Tennessee (119)
Texas (1102)
United States (27684)
Utah (215)
Virginia (194)
Washington D.C. (78)
Washington State (655)
West Virginia (4)
Wisconsin (80)
There are 850,222 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
OPTIC and Mechanica Partners Expand Strategic Collaboration to Power AI-Driven Venture Creation Across Multiple Programs
Collaboration highlights Mechanica Partners’ innovative use of Optic’s BIOPTIC platform to bridge scientific discovery and strategic business insights for accelerated biotech portfolio growth
June 6, 2025
·
1 min read
Press Releases
Phio Pharmaceuticals Announces Strategic Initiative to Create Awareness of the Comprehensive INTASYL siRNA Portfolio
- Robert Infarinato named VP, Strategic Development - Lisa Carson named as new VP, Finance and Administration
June 6, 2025
·
5 min read
Press Releases
Neural’s Partner CWE to Open Store No. 16 in the City of Bonn and Invitation to Meet Hanf.com at Mary Jane Berlin 2025
June 6, 2025
·
5 min read
Press Releases
PharmaDrug Announces Strategic Review Process Intended to Maximize Shareholder Value
June 6, 2025
·
5 min read
Press Releases
CD Genomics Unveils Advanced LncRNA Microarray Service to Accelerate Transcriptomic Research
June 6, 2025
·
1 min read
Press Releases
Myllia Biotechnology Unveils First-Ever Platform Enabling Genome-Wide CRISPR Screens in Primary Human Macrophages and Dendritic Cells
The breakthrough VISTA™ platform opens new frontiers in drug target discovery and leverages sequencing technology from Ultima Genomics.
June 6, 2025
·
1 min read
Layoff Tracker
Capsida Downsizes as Part of Shift to Clinical-Stage Company
Follow along as
BioSpace
tracks job cuts and restructuring initiatives throughout 2025.
June 6, 2025
·
220 min read
·
BioSpace Editorial Staff
Radiopharmaceuticals
Perspective Therapeutics Brings Energy to the Radiopharma World
The Seattle-based company came to ASCO25 with new data on its neuroendocrine tumor–treating lead therapy, with big vibes and speedy speech.
June 6, 2025
·
2 min read
·
Dan Samorodnitsky
GLP-1
EU Regulators Confirm Rare Vision Loss Risk for Novo’s Semaglutide
Given the evidence, the committee has recommended that the labels for Novo Nordisk’s Wegovy and Ozempic be updated to include the “very rare” risk of non-arteritic anterior ischemic optic neuropathy.
June 6, 2025
·
1 min read
·
Annalee Armstrong
IgA nephropathy
Otsuka Sees ‘Impressive’ Proteinuria Reduction in Phase III IgAN Trial
Otsuka’s investigational antibody sibeprenlimab approximately halved levels of this key biomarker in patients with immunoglobulin A nephropathy.
June 6, 2025
·
2 min read
·
Tristan Manalac
1 of 85,023
Next
